Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study.
Annals of internal medicine 2021 ; 174: 1483-1487.
Clift AK, Saatci D, Coupland CAC, Dambha-Miller H, Hippisley-Cox J
DOI : 10.7326/M21-1375
PubMed ID : 34338553
PMCID : PMC8343340
URL : https://www.acpjournals.org/doi/10.7326/M21-1375
Abstract
Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study.